KD Logo

Arcus Biosciences Inc [RCUS] stock for 202,720 USD was sold by Jarrett Jennifer

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Arcus Biosciences Inc shares valued at $202,720 were sold by Jarrett Jennifer on Mar 27 ’24. At $17.55 per share, Jarrett Jennifer sold 11,551 shares. The insider’s holdings dropped to 215,253 shares worth approximately $3.24 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Also, Jarrett Jennifer sold 13,449 shares, netting a total of over 240,941 in proceeds. Following the sale of shares at $17.92 each, the insider now holds 226,804 shares.

Before that, Jarrett Jennifer had sold 34,070 shares from its account. In a trade valued at $685,148, the Chief Operating Officer traded Arcus Biosciences Inc shares for $20.11 each. Upon closing the transaction, the insider’s holdings decreased to 34,070 shares, worth approximately $3.62 million.

As published in their initiating research note from BofA Securities on November 18, 2022, Arcus Biosciences Inc [RCUS] has been a Neutral and the price target has been revised to $33. Analysts at Morgan Stanley started covering the stock with ‘”an Overweight”‘ outlook in a report released in mid October. Earlier on November 24, 2020, Berenberg initiated its rating. Their recommendation was “a Buy” for RCUS stock.

Analyzing RCUS Stock Performance

During the last five days, there has been a drop of approximately -0.59%. Over the course of the year, Arcus Biosciences Inc shares have dropped approximately -21.10%. Shares of the company reached a 52-week high of $20.31 on 02/27/24 and a 52-week low of $14.10 on 04/19/24. A 50-day SMA is recorded $15.93, while a 200-day SMA reached $16.58. Nevertheless, trading volume fell to 0.19 million shares from 0.41 million shares the previous day.

Support And Resistance Levels for Arcus Biosciences Inc (RCUS)

According to the 24-hour chart, there is a support level at 14.12, which, if violated, would cause prices to drop to 13.88. In the upper region, resistance lies at 14.82. The next price resistance is at 15.28. RSI (Relative Strength Index) is 42.43 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.00, which suggests the price will decrease in the coming days. Percent R is at 96.25%, indicating bearish price movement. Stochastics%K at buying indicates that the stock is to be held.

Most Popular